Skip to content

Heterogeneity Informed Nutrition Therapy for Gestational Diabetes Mellitus

Heterogeneity Informed Nutrition Therapy for Gestational Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04187521
Acronym
HINT-GDM
Enrollment
19
Registered
2019-12-05
Start date
2020-02-10
Completion date
2022-11-30
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Keywords

gestational diabetes, pregnancy, diet, nutrition

Brief summary

The hypothesis for this study is that women with different physiologic subtypes of gestational diabetes (GDM) (insulin secretion deficit vs. insulin sensitivity deficit) will differ in their glycemic responses to meals with different portions of dietary macronutrients. Investigators will determine GDM subtype based on glucose and insulin levels taken at multiple time points during an oral glucose tolerance test. Participants will consume two meals with different macronutrient content while wearing a continuous glucose monitor which will allow investigators to assess the glycemic response to the meals.

Detailed description

Diabetes mellitus can be classified based on impairments in two different physiologic parameters, insulin secretion and insulin sensitivity. The investigator involved in this trial has previously defined GDM subtypes based on underlying physiology and demonstrated that women with GDM and predominant sensitivity defects have an elevated risk of adverse pregnancy outcomes, while women with predominant secretion defects do not appear to carry the same risk. This supports the idea that not all gestational diabetes is the same. Ideal treatment strategies may differ between GDM subtypes. In this trial, investigators will evaluate the postprandial glycemic response to two test meals with different macronutrient content in different GDM physiologic subtypes. Two test meals with different macronutrient proportions have been designed by research dieticians. Participants will eat test meals at home for breakfast in a randomized order after an overnight fast. Participants will complete food and blood sugar diaries, and will wear a continuous glucose monitor, which will measure postprandial glucose.

Interventions

OTHERMeal A

A breakfast meal with a specific macronutrient proportions.

OTHERMeal B

A breakfast meal with a specific macronutrient proportions.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Diagnosis of gestational diabetes

Exclusion criteria

* Known diabetes mellitus that preceded pregnancy * Food allergies to components of the test meals * Use of medications known to affect glucose tolerance * Have extensive skin changes or diseases making CGM sensor use problematic * Demonstrated allergy to CGM adhesive * Inability to adhere to the swimming and bathing instructions * Plan to have MRI, CT scan, X Ray or diathermy (heat treatment) during the 7-day CGM study period * Inability to adhere to Vitamin C guidelines during study period (using more than 500 mg of Vitamin C/day which could interfere with the CGM) * Use of medications known to affect glucose tolerance * In the opinion of the principal investigator (PI), demonstrate any other factor likely to limit compliance with the protocol

Design outcomes

Primary

MeasureTime frameDescription
Peak blood glucose following test meal (CGM)15 mins - 3 hoursPeak postprandial blood glucose after test meal assessed by continuous glucose monitor

Secondary

MeasureTime frameDescription
One-hour post prandial blood glucose following test meal (SMBG)1 hour1 hour postprandial blood glucose after test meal on day 2 and day 3 assessed by glucometer
Glucose area under the curve following test meal (CGM)3 hoursArea under the curve of CGM measured glucose from the start of the test meal to three hours after the test meal is started
Meal taste1 hourPalatability of the test meals measured using a visual analog scale
Meal satiety3 hoursSatiety following meal measured using a visual analog scale
Meal completion1 hourPercent of test meal finished assessed by photo of completed meal
Peak blood glucose following lunch on day of test meal (CGM)15 mins - 3 hoursPeak postprandial blood glucose after lunch on days of test meals assessed by CGM
One-hour post prandial blood glucose following lunch on day of test meal (SMBG)1 hour1 hour postprandial blood glucose after lunch on days of test meals assessed by glucometer
Carbohydrate content of lunch after test meal6 hoursCarbohydrate content (grams) of lunch meal following the test meal
Calorie content of lunch after test meal6 hoursCalorie content of lunch meal following the test meal
Peak blood glucose following dinner on day of test meals (CGM)15 mins - 3 hoursPeak postprandial blood glucose after dinner on day of test meal assessed by CGM
One-hour postprandial blood glucose following dinner on day of test meal (SMBG)1 hour1 hour postprandial blood glucose after dinner on day of test meal assessed by glucometer
Carbohydrate content of dinner after test meal6 hoursCarbohydrate content (grams) of dinner meal following the test meal
Calorie content of dinner after test meal6 hoursCalorie content of dinner meal following the test meal
Mean blood glucose24 hoursMean blood glucose on the day of the test meal assessed by CGM
Time in target range24 hoursLength of time at which the patient's BG are within goal range (65-140 mg/dl) on the day of test meal assessed by CGM
Time above target range24 hoursLength of time at which the patient's BG is \>140 mg/dl on the day of test meals assessed by CGM
Time below target range24 hoursLength of time at which the patient's BG is \<65 mg/dl on the day of test meals assessed by CGM
Total caloric intake on the days of test meals24 hoursTotal calorie intake on the day that the test meal is consumed

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCamille E Powe, MD

Massachusetts General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026